In the premiere episode of Mind, Body, & the Pause, Soma Mandal, MD, is joined by Manisha Parulekar, MD, and Jocelyn Carlo, MD, FACOG, to discuss the stages of the menopause transition.
|Podcasts|November 18, 2020
S2E7: Surgeons Panel: The state of gynecologic surgery
Author(s)Lindsey Carr, Editor
In this episode of Pap Talk, Contemporary OB/GYN Deputy Editor Jon I. Einarsson, MD, MPH, PhD, moderates a discussion with Robert K. Zurawin, MD, and Gaby Moawad, MD, on the new and existing surgical technologies and techniques available in ob/gyn.
Advertisement
Zurawin is an adjunct associate professor at the Baylor College of Medicine, Department of ob/gyn.
Moawad is a clinical associate professor of ob/gyn at the George Washington University School of Medicine and Health Sciences, and founder of the Center for Endometriosis and Advanced Pelvic Surgery.
Disclosures
Zurawin is the principal medical advisor for Memic Innovative Surgery Ltd., the company that created the Hominis surgical system. Moawad is on the Speakers Bureau, Intuitive Surgical.
Advertisement
Related to this article
Mental health, bias, and trauma shape sexual health visits, and histories should assess function, not just risk, according to Sameena Rahman, MD.
This FAQ summarizes a Special Report discussion on off-label testosterone dosing, application, cost, and lab monitoring in women.
This FAQ summarizes a Special Report discussion on how two experts decide who is a candidate for testosterone therapy in women, from symptoms and context to hormone state vs age.
This FAQ summarizes a Special Report discussion of what the evidence does and does not establish about testosterone therapy in women.
Kanchi Chadha, MD, FACOG, MSCP, supports reconsidering MHT boxed warnings but says the FDA cited no study behind the change.
HRSA will award up to $1 million to a single organization to update the Women's Preventive Services Guidelines through the new WISH program.
Real-world data show maternal RSVpreF vaccination was 82% effective against infant RSV LRTI hospitalization through 3 months.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Centers for Medicare, Medicaid Services includes AMA's obstetric codes in 2027 fee schedule
2
FAQ: How is off-label testosterone dosed and monitored in women?
3
Q&A: Soma Mandal, MD, MSCP, on FDA boxed warning removals for MHT
4
Mental health, bias, and trauma: Building trust in sexual medicine
5